FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064455 [Registered on: 19/03/2024] Trial Registered Prospectively
Last Modified On: 01/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Press Kukundara Marma situated in low back region for the treatment of low back pain(Katishoola) 
Scientific Title of Study   An Anatomical Study on Kukundara Marma with special reference to Katishoola (Low Back Pain) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ragini devi pal 
Designation  MD Scholar 
Affiliation  Institute of Medical Science BHU 
Address  Department of Rachana Sharir Faculty of Ayurveda IMS BHU Varanasi Uttar Pradesh

Varanasi
UTTAR PRADESH
221005
India 
Phone  7800528806  
Fax    
Email  raginipal1996@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ragini devi pal 
Designation  Junior Resident 
Affiliation  Institute of Medical Science BHU 
Address  Department of Rachana Sharir Faculty of Ayurveda IMS BHU Varanasi Uttar Pradesh


UTTAR PRADESH
221005
India 
Phone  7800528806  
Fax    
Email  raginipal1996@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Vijay laxmi Gautam 
Designation  Professor 
Affiliation  Institute of Medical Science BHU 
Address  Department of Rachana Sharir Faculty of Ayurveda IMS BHU Varanasi Uttar Pradesh

Varanasi
UTTAR PRADESH
221005
India 
Phone  9451440263  
Fax    
Email  vlaxmi40@gmail.com  
 
Source of Monetary or Material Support  
Sir Sunderlal Hospital BHU Varanasi OPD No 16C 
 
Primary Sponsor  
Name  Institute of Medical Science  
Address  Institute of Medical Science Banaras Hindu University Varanasi 221005 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ragini Devi Pal  Sir Sundarlal Hospital  Department of Panchkarma OPD No. 16C Indian Medicine Wing Varanasi Uttar Pradesh
Varanasi
UTTAR PRADESH 
7800528806

raginipal1996@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M479||Spondylosis, unspecified. Ayurveda Condition: VATAJASULAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Tryodashanga guggula and Dashmula kwath, Reference: Bhaishajya ratnawali, Route: Oral, Dosage Form: Guggulu , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 15 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
2Intervention ArmProcedure-marmacikitsA, मर्मचिकित्सा (Procedure Reference: Sushrut Sharir 6 chapter, Procedure details: stimulation of kukundara marma 12 to 15 times per minutes(for 3 minute) twice daily for 10 days )
(1) Medicine Name: Tryodashanga gugglu and Dashmula kwath, Reference: Bhaishajya ratnawali, Route: Oral, Dosage Form: Guggulu, Dose: 500(mg), Frequency: bd, Duration: 15 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  clinical symptoms with or without radiological changes. 
 
ExclusionCriteria 
Details  1. Patients below 20 years and above 70 years of age will be excluded.
2. Patient suffering from paralysis.
3. Uncontrolled diabetes mellitus, cardiovascular disease, neoplastic disorder, any severe illness.
4. Pregnancy
5. Severe malnourished, debilitated
6. Myelopathy, any type of malignancy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief in sign and symptoms of the disease. The main sign and symptoms in the study are as follow
Pain in Kati(lumbar region)
Stiffness in Kati
Numbness
Tingling sensation
Headache
Weakness of lower limbs
Giddiness
 

30 days study with follow up at 15 days 
 
Secondary Outcome  
Outcome  TimePoints 
education in scoring of following scale;
Visual Analog Scale 
30 days study with follow up at 15 days  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/04/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   50 cases of Katishoola (Low Back Pain) will be included in this interventional study which will be randomly divided in to two groups of 25 patients in each group. One group will be prescribed Tryodashanga Guggulu and Dashmoola Kwath. Second group will be prescribed Tryodashanga Guggulu, Dashmoola Kwath and Kukundara Marma Chikitsa. 
Close